Unlearn uses AI to create digital twins of clinical trial participants, fundamentally transforming how clinical studies are designed and executed. Clinical trials are slow, expensive, and often fail — not because the science is wrong, but because trial design is inefficient and outcomes are hard to predict. Unlearn's platform generates a digital twin for every participant at the start of a study, simulating outcomes at every future time point with remarkable precision. This enables confident decision-making from day one, minimizes the risk of trial failure, cuts costs by reducing the need for large control groups, and accelerates development timelines. The platform is delivered through a state-of-the-art, easy-to-use interface that makes powerful AI simulation accessible to clinical teams.
Comments
Loading comments…